Literature DB >> 27581459

ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.

Marisa A Jeffries1, Kelly Urbanek2, Lester Torres3, Stacy Gelhaus Wendell4, Maria E Rubio5, Sharyl L Fyffe-Maricich6.   

Abstract

UNLABELLED: Growing evidence shows that mechanisms controlling CNS plasticity extend beyond the synapse and that alterations in myelin can modify conduction velocity, leading to changes in neural circuitry. Although it is widely accepted that newly generated oligodendrocytes (OLs) produce myelin in the adult CNS, the contribution of preexisting OLs to functional myelin remodeling is not known. Here, we show that sustained activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in preexisting OLs of adult mice is sufficient to drive increased myelin thickness, faster conduction speeds, and enhanced hippocampal-dependent emotional learning. Although preexisting OLs do not normally contribute to remyelination, we show that sustained activation of ERK1/2 renders them able to do so. These data suggest that strategies designed to push mature OLs to reinitiate myelination may be beneficial both for enhancing remyelination in demyelinating diseases and for increasing neural plasticity in the adult CNS. SIGNIFICANCE STATEMENT: Myelin is a crucial regulator of CNS plasticity, function, and repair. Although it is generally accepted that new myelin production in the adult CNS is initiated by newly generated oligodendrocytes (OLs), great interest remains in additionally driving mature preexisting OLs to make myelin. The ability to induce myelination by the larger population of preexisting OLs carries the potential for enhanced remyelination in demyelinating diseases and increased neural plasticity in the adult CNS. Here, we show that sustained activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathway is sufficient to drive mature OLs in the adult mouse CNS to reinitiate myelination, leading to new myelin wraps and functional changes.
Copyright © 2016 the authors 0270-6474/16/369186-15$15.00/0.

Entities:  

Keywords:  ERK MAP kinase; intracellular signaling; myelin; myelin plasticity; oligodendrocyte; remyelination

Mesh:

Substances:

Year:  2016        PMID: 27581459      PMCID: PMC5005725          DOI: 10.1523/JNEUROSCI.1444-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

1.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

2.  Control of myelination by specific patterns of neural impulses.

Authors:  B Stevens; S Tanner; R D Fields
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

3.  Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brain.

Authors:  Kelly Michel; Tianna Zhao; Molly Karl; Katherine Lewis; Sharyl L Fyffe-Maricich
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

4.  Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala.

Authors:  M S Fanselow; J J Kim
Journal:  Behav Neurosci       Date:  1994-02       Impact factor: 1.912

5.  Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.

Authors:  Kathryn K Bercury; JinXiang Dai; Hilary H Sachs; Jared T Ahrendsen; Teresa L Wood; Wendy B Macklin
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

6.  On the delay-dependent involvement of the hippocampus in object recognition memory.

Authors:  Rebecca S Hammond; Laura E Tull; Robert W Stackman
Journal:  Neurobiol Learn Mem       Date:  2004-07       Impact factor: 2.877

7.  Motor skill learning requires active central myelination.

Authors:  Ian A McKenzie; David Ohayon; Huiliang Li; Joana Paes de Faria; Ben Emery; Koujiro Tohyama; William D Richardson
Journal:  Science       Date:  2014-10-17       Impact factor: 47.728

Review 8.  The novel object recognition memory: neurobiology, test procedure, and its modifications.

Authors:  M Antunes; G Biala
Journal:  Cogn Process       Date:  2011-12-09

9.  Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.

Authors:  Maria E Sheean; Erik McShane; Cyril Cheret; Jan Walcher; Thomas Müller; Annika Wulf-Goldenberg; Soraya Hoelper; Alistair N Garratt; Markus Krüger; Klaus Rajewsky; Dies Meijer; Walter Birchmeier; Gary R Lewin; Matthias Selbach; Carmen Birchmeier
Journal:  Genes Dev       Date:  2014-02-01       Impact factor: 11.361

10.  Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.

Authors:  Abbe H Crawford; Richa B Tripathi; Sarah Foerster; Ian McKenzie; Eleni Kougioumtzidou; Matthew Grist; William D Richardson; Robin J M Franklin
Journal:  Am J Pathol       Date:  2016-01-07       Impact factor: 4.307

View more
  50 in total

Review 1.  Myelin plasticity in adulthood and aging.

Authors:  Timothy W Chapman; Robert A Hill
Journal:  Neurosci Lett       Date:  2019-11-22       Impact factor: 3.046

2.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.

Authors:  Miki Furusho; Akihiro Ishii; Rashmi Bansal
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

3.  Enhancing Remyelination through a Novel Opioid-Receptor Pathway.

Authors:  Jeremy C Borniger; Zoe C Hesp
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

4.  Enriched environment modulates behavior, myelination and augments molecules governing the plasticity in the forebrain region of rats exposed to chronic immobilization stress.

Authors:  Gangadharan Thamizhoviya; Arambakkam Janardhanam Vanisree
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

5.  TGFα preserves oligodendrocyte lineage cells and improves white matter integrity after cerebral ischemia.

Authors:  Xuejiao Dai; Jie Chen; Fei Xu; Jingyan Zhao; Wei Cai; Zeyu Sun; T Kevin Hitchens; Lesley M Foley; Rehana K Leak; Jun Chen; Xiaoming Hu
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-05       Impact factor: 6.200

6.  Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood.

Authors:  Akihiro Ishii; Miki Furusho; Wendy Macklin; Rashmi Bansal
Journal:  Glia       Date:  2019-02-13       Impact factor: 7.452

7.  Dual specificity phosphatase 15 regulates Erk activation in Schwann cells.

Authors:  José F Rodríguez-Molina; Camila Lopez-Anido; Ki H Ma; Chongyu Zhang; Tyler Olson; Katharina N Muth; Matthias Weider; John Svaren
Journal:  J Neurochem       Date:  2017-01-09       Impact factor: 5.372

8.  Sustained MAPK/ERK Activation in Adult Schwann Cells Impairs Nerve Repair.

Authors:  Ilaria Cervellini; Jorge Galino; Ning Zhu; Shannen Allen; Carmen Birchmeier; David L Bennett
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

9.  Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Authors:  Steven M Wellman; Kelly Guzman; Kevin C Stieger; Lauren E Brink; Sadhana Sridhar; Mitchell T Dubaniewicz; Lehong Li; Franca Cambi; Takashi D Y Kozai
Journal:  Biomaterials       Date:  2020-02-06       Impact factor: 12.479

10.  R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.

Authors:  Miriam Sanz-Rodriguez; Agnès Gruart; Juan Escudero-Ramirez; Fernando de Castro; José María Delgado-García; Francisco Wandosell; Beatriz Cubelos
Journal:  J Neurosci       Date:  2018-05-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.